These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2338322)

  • 21. [New developments in the treatment of nausea and vomiting caused by chemotherapy].
    de Wit R; van Alphen MM
    Ned Tijdschr Geneeskd; 2003 Apr; 147(15):690-4. PubMed ID: 12722531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of acute emesis.
    Singhal S; Mehta J
    J Assoc Physicians India; 1995 Aug; 43(8):560-2. PubMed ID: 8772978
    [No Abstract]   [Full Text] [Related]  

  • 23. Preventing emesis in lung cancer patients.
    J Support Oncol; 2007 Feb; 5(2):79-80. PubMed ID: 17348365
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
    Jordan K; Voigt W; Schmoll HJ
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of vomiting due to cytostatic treatment].
    Bruntsch U
    MMW Munch Med Wochenschr; 1979 Nov; 121(44):1450-1. PubMed ID: 42847
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of emesis accompanying antitumor chemotherapy].
    Zaucha R; Zaucha JM; Jassem J
    Przegl Lek; 1994; 51(1):49-52. PubMed ID: 8208995
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacist management of antiemetic therapy under protocol in an oncology clinic.
    Martin JK; Norwood MB
    Am J Hosp Pharm; 1988 Jun; 45(6):1322-8. PubMed ID: 3414699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of ondansetron, a 5-HT3 receptor antagonist, as a new type of antiemetic in pediatric oncology].
    Csáki C; Ferencz T; Koós R; Schuler D; Borsi J
    Orv Hetil; 1993 Jun; 134(25):1363-7. PubMed ID: 8332356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
    Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
    Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring chemotherapy-induced nausea and emesis.
    Martin CG; Rubenstein EB; Elting LS; Kim YJ; Osoba D
    Cancer; 2003 Aug; 98(3):645-55. PubMed ID: 12879484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms and management of nausea and emesis.
    Dicato M
    Oncology; 1996 Jun; 53 Suppl 1():1-3. PubMed ID: 8692544
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapy-induced nausea and vomiting: state of the art in 2006.
    Schwartzberg L
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):3-8. PubMed ID: 16499138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
    Jordan K; Kasper C; Schmoll HJ
    Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community.
    Hickok JT; Roscoe JA; Morrow GR; King DK; Atkins JN; Fitch TR
    Cancer; 2003 Jun; 97(11):2880-6. PubMed ID: 12767103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial.
    Dibble SL; Luce J; Cooper BA; Israel J; Cohen M; Nussey B; Rugo H
    Oncol Nurs Forum; 2007 Jul; 34(4):813-20. PubMed ID: 17723973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
    Jordan K; Sippel C; Schmoll HJ
    Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Digestive disorders induced by chemotherapeutic treatment].
    Gisselbrecht C; Aguerri MF
    Soins; 1985 Jul; (457-458):13-7. PubMed ID: 3851553
    [No Abstract]   [Full Text] [Related]  

  • 39. Emesis and anti-emesis.
    Naylor RJ; Rudd JA
    Cancer Surv; 1994; 21():117-35. PubMed ID: 8564988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-emetic therapy in cancer chemotherapy: current status.
    Herrstedt J; Dombernowsky P
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.